Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

Epigenetic alterations have been recognized as important contributors to the pathogenesis of PDAC. However, the role of histone variants in pancreatic tumor progression is still not completely understood. The ...

Source: BMC Cancer - December 2, 2017 Category: Cancer & Oncology Authors: Monika Bauden, Theresa Kristl, Agata Sasor, Bodil Andersson, Gy örgy Marko-Varga, Roland Andersson and Daniel Ansari Tags: Research article Source Type: research